Product Images Donepezil Hydrochloride

This text provides information on the mean change from the baseline in ADAS-cog score for different drug treatments (Donepezil Hydrochloride 10 mg/day, Donepezil Hydrochloride 5 mg/day, and Placebo) over time intervals (6, 12, 18, 24, 30 weeks). It indicates the improvement and decline in cognitive function based on the ADAS-cog assessment.*

This text appears to be showing the Cumulative Percentage of Patients in a study related to treatment with Donepezil Hydrochloride for Alzheimer's disease. The information includes data on changes in ADAS-cog scores for different treatment groups. The percentages represent the improvement in patients' cognitive function after treatment with Donepezil Hydrochloride compared to Placebo. The data is presented in a graphical format showing the change from baseline in the cognitive function of patients.*

This text provides a chart showing the percentage of patients within different treatment groups (Donepezil Hydrochloride 10 mg/day, Donepezil Hydrochloride 5 mg/day, and Placebo) based on their CIBIC-plus Rating. The chart categorizes the patients into levels of improvement ranging from Markedly Improved to Markedly Worse.*

This text appears to describe a clinical trial comparing the effects of different dosages of Donepezil Hydrochloride and placebo on cognitive improvement or decline over a period of 15 weeks. The study includes a baseline measure and the administration of two different daily dosages of Donepezil Hydrochloride, namely 10mg and 5mg, as well as a placebo. The evaluation seems to focus on clinical improvement or decline in cognitive function over the treatment period.*

This text appears to show the change in clinical improvement from baseline after being treated with Donepezil Hydrochloride for 10mg per day over a period of months. The data suggests a positive change in clinical improvement compared to the baseline and a comparison with a placebo group.*

Not available.*

This text provides information about a medication containing 5 mg of donepezil hydrochloride. It includes details such as the usual dosage, storage instructions, and a reminder to keep the drug out of reach of children. The medication is distributed by Hisun Pharmaceuticals USA, Inc., with manufacturing taking place in China. You can consult the package insert for complete prescribing information.*

This text contains instructions for storing and dispensing a drug product. It advises storing the product at a temperature range of 20°C to 25°C (68°F to 77°F), with limited excursions to 15°C to 30°C (59°F to 86°F). It also instructs to dispense the medication in a tight container and emphasizes keeping all drugs away from children. The product is distributed by Hisun Pharmaceuticals USA, Inc., with manufacturing taking place in China. The text is dated Rev. 01/19.*

This is a description of a medication containing 5 mg of donepezil hydrochloride, USP. The usual dosage instructions can be found in the package insert. It should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be dispensed in a tight container and kept out of the reach of children. It is distributed by Hisun Pharmaceuticals USA, Inc. in Bridgewater, NJ 08807 USA, and manufactured in China. The revision date is 01/19.*

This text provides information about a medication that contains 10 mg of donepezil hydrochloride, USP. It includes instructions to refer to the package insert for complete information, store the tablets within a specific temperature range, dispense in a tight container, and keep the medication out of the reach of children. The medication is distributed by Hisun Pharmaceuticals USA, Inc., and manufactured in China.*

This text provides important information about donepezil hydrochloride tablets. Each tablet contains 10 mg of the active ingredient. The usual dosage is to be determined by referring to the package insert for detailed prescribing information. The tablets should be stored at temperatures between 20°C to 25°C, with excursions allowed to 15°C to 30°C. They should be kept in a tightly closed container and away from children. The product is distributed by Hisun Pharmaceuticals USA, Inc., with manufacturing done in China. (Revision date: 01/19)*

This is a description of Donepezil HCI Orally Disintegrating Tablets, USP. Each tablet contains 10 mg of donepezil hydrochloride, USP. The usual dosage information can be found in the package insert. It is recommended to store the tablets at 20° to 25°C (68° to 77°F), with excursions permitted up to 15° to 30°C (59° to 86°F). Dispense the tablets in a tight container and keep all drugs out of the reach of children. The tablets are distributed by Hisun Pharmaceuticals USA, Inc. in Bridgewater, NJ, USA and manufactured in China.*